Latest / Cleveland Clinic Cancer Advances
From Blood Sugar to Blood Cancer: Surprising Benefits of GLP-1s
Abhay Singh, MD, MPH, Director of the CHIP Clinic at Cleveland Clinic, joins the Cancer Advances Podcast to discuss a major new study exploring the link between GLP-1 receptor agonists and the risk of hematologic malignancies in patients with diabetes. Tune in to hear how GLP-1s, best known for managing diabetes and obesity, may hold promise for cancer prevention and what this could mean for future cardio-oncology care.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.